T/CACM 1462-2023 The guideline for the intervention of pre-disease in the key population of menopause syndrome (perimenopause syndrome)

Scope

Main Technical Content: Preface II. Introduction III. 1. Scope 2. Normative Reference Documents 3. Terms and Definitions 4. Epidemiology 5. Etiology and Pathogenesis 6. Screening 36.1. Key Populations for Perimenopausal Syndrome 36.2. Screening for Perimenopausal Syndrome 37. Intervention 57.1. Principles of Intervention 57.2. Intervention for Perimenopausal Syndrome 57.3. Intervention for Key Populations with Perimenopausal Syndrome 108. Follow-up 20. Appendix A (Informational) - Female Menopausal Syndrome Assessment Scale (Modified Kupperman Score) 21. Appendix B (Informational) - One-Minute Osteoporosis Risk Test 22. Appendix C (Informational) - Asian Osteoporosis Self-Screen Tool (Applicable to Postmenopausal Osteoporosis) 23. Appendix D (Informational) - Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment—China—PAR 24. Appendix E (Informational) - Zung Self-Rating Anxiety Scale (SAS) 25. Appendix F (Informational) - Zung Self-Rating Depression Scale (SDS) 27. References 29.

Development Information

Related Standards